Neuroblastoma

• Health & Medicine

New neuroblastoma treatment combo helps more children with relapsed disease

We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.   We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.  

10 January 2024

• For Researchers

Kinder and more effective - why childhood cancers need specific treatments

Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments. Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments.

3 September 2021

• Health & Medicine

Life-extending immunotherapy approved on NHS for children with neuroblastoma

Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life. Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life.

13 July 2018

• Health & Medicine

Testing a new immunotherapy treatment for neuroblastoma

A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma. A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.

3 May 2017

• Health & Medicine

Long term benefits of immunotherapy emerging for some patients, though key questions remain

A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research. A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research.

10 April 2017

• Science & Technology
• Health & Medicine

Cellular ‘kryptonite’ poses challenges in tackling childhood nerve cancer

Our scientists have discovered that neuroblastoma cells can produce a cellular ‘kryptonite’ that seems to sap the power from nearby immune cells. Our scientists have discovered that neuroblastoma cells can produce a cellular ‘kryptonite’ that seems to sap the power from nearby immune cells.

1 August 2015

• Science & Technology
• Health & Medicine

Childhood cancer cells drain immune system’s batteries

Cancer cells in neuroblastoma release a molecule that breaks down a key energy source for the body’s immune cells, leaving them too drained to fight the disease Cancer cells in neuroblastoma release a molecule that breaks down a key energy source for the body’s immune cells, leaving them too drained to fight the disease

1 August 2015

Little Star award for inspirational Harley

Manchester youngster Harley Renshaw has had his courage recognised with a special award as he fights cancer in his kidney, neck, lung and bones. Manchester youngster Harley Renshaw has had his courage recognised with a special award as he fights cancer in his kidney, neck, lung and bones.

3 December 2014

• Health & Medicine

“It upset me enormously that children were dying, and I wanted to do something to help them” – Andy’s story

Read Professor Andy Pearson's story, exploring his career researching childhood cancer and what the future holds for the BEACON neuroblastoma trial. Read Professor Andy Pearson's story, exploring his career researching childhood cancer and what the future holds for the BEACON neuroblastoma trial.

25 July 2014

Simple blood test could improve treatment for deadly childhood cancer

A simple blood test could pinpoint which children are unlikely to respond to treatment for a particularly aggressive form of neuroblastoma A simple blood test could pinpoint which children are unlikely to respond to treatment for a particularly aggressive form of neuroblastoma

3 March 2014

• Health & Medicine

A groundbreaking clinical trial for children with aggressive neuroblastoma

Neuroblastoma is a type of childhood cancer and our researchers are pioneering new clinical trials to tackle aggressive forms of the disease - how does it work? Neuroblastoma is a type of childhood cancer and our researchers are pioneering new clinical trials to tackle aggressive forms of the disease - how does it work?

13 August 2013

Cancer Research UK launches international trial for treatment of relapsed neuroblastoma

Cancer Research UK scientists and paediatric cancer specialists have launched the BEACON-neuroblastoma trial, which aims to find the best chemotherapy regimen for children and young adults with recurring or resistant neuroblastoma. Researchers will also investigate whether blocking the growth of new blood vessels supplying the tumours can enhance this treatment. Cancer Research UK scientists and paediatric cancer specialists have launched the BEACON-neuroblastoma trial, which aims to find the best chemotherapy regimen for children and young adults with recurring or resistant neuroblastoma. Researchers will also investigate whether blocking the growth of new blood vessels supplying the tumours can enhance this treatment.

13 August 2013